V2X (VVX) Q3 2026 Earnings Call Transcript

V2X reported Q3 2026 revenue of $1.27 billion, up 9% year over year, and adjusted diluted EPS of $1.64, up 19%; it raised full-year revenue guidance to $4.95 billion–$5.1 billion and adjusted EPS guidance to $6.15–$6.55. Backlog was $12.8 billion, including $2.6 billion funded, while Middle East revenue fell 30% year over year and is expected to weigh on Q4 growth. Management cited demand in Asia-Pacific and engineering, a 1.2x quarterly book-to-bill ratio, and 6% recompete exposure in 2027, while noting uncertainty around award timing.

Analysis

The better read-through is improving mix potential, not yet a proven margin inflection. Bookings reportedly carry above-company margins, and a higher share of fixed-price/T&M work could lift profitability as awards ramp; however, Q3 EBITDA grew slower than revenue, while the implied Q4 margin step-up relies partly on productivity and expense timing. Treat the 2027 expansion claim as an execution test, not a booked outcome.

Backlog quality is a key diligence point: only about one-fifth is funded, so headline backlog offers less near-term revenue protection than its size suggests. The gap between positive adjusted operating cash flow and negative year-to-date GAAP operating cash flow also warrants reconciliation for working-capital movements and adjustments before underwriting deleveraging. Lower net debt helps interest sensitivity, but reaching the leverage target still depends on cash conversion.

Near term, guidance raises support sentiment, but the fourth-quarter growth deceleration and Middle East drawdown temper the beat narrative. Over 1–3 months, award adjudication around the election cycle and delivery against the Q4 margin step-up are the principal catalysts. Over 6–18 months, Asia-Pacific awards and product conversion could improve mix; counter-UAS customer count and rapid fielding are validation signals, not evidence yet of material recurring revenue. The national-security activity tailwind is potentially episodic, so extrapolating it into a durable growth rate is the contrarian risk. A broad defense-services peer rally could also leave VVX priced for margin gains before they appear.

Key Decisions for Investors

• Maintain a constructive but valuation-disciplined bias on VVX; consider initiating or adding only on post-earnings consolidation, rather than treating the guidance increase as proof of a structural re-rating. No price target without current valuation and estimate data.
• Use the next earnings update as the 1–3 month decision point: verify Q4 adjusted EBITDA margin against management’s implied step-up and inspect GAAP-to-adjusted cash-flow reconciliation. Missed margin delivery or persistent weak GAAP cash conversion would falsify the improving-quality thesis.
• Track funded backlog conversion, award timing, and 2027 program ramp—not total backlog or bid volume alone. Delayed adjudications, further Middle East scope reductions without replacement awards, or national-security activity fading faster than new work ramps would weaken the growth case.
• Treat Tempest and Asia-Pacific as upside watch items, not standalone reasons to pay a premium: seek disclosed product revenue, follow-on production awards, and measurable margin contribution before upgrading the structural thesis.